Eli Lilly & Co. (LLY)
1170.27
+10.27
(+0.89%)
USD |
NYSE |
Sep 02, 10:55
Eli Lilly Net Income (Annual) : 20.64B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 20.64B |
| December 31, 2024 | 10.59B |
| December 31, 2023 | 5.240B |
| December 31, 2022 | 6.245B |
| December 31, 2021 | 5.582B |
| December 31, 2020 | 6.194B |
| December 31, 2019 | 4.638B |
| December 31, 2018 | 3.151B |
| December 31, 2017 | -204.10M |
| December 31, 2016 | 2.738B |
| December 31, 2015 | 2.408B |
| December 31, 2014 | 2.390B |
| December 31, 2013 | 4.685B |
| December 31, 2012 | 4.089B |
| December 31, 2011 | 4.348B |
| December 31, 2010 | 5.070B |
| December 31, 2009 | 4.329B |
| December 31, 2008 | -2.072B |
| December 31, 2007 | 2.953B |
| December 31, 2006 | 2.663B |
| December 31, 2005 | 2.002B |
| December 31, 2004 | 1.810B |
| December 31, 2003 | 2.561B |
| Date | Value |
|---|---|
| December 31, 2002 | 2.708B |
| December 31, 2001 | 2.809B |
| December 31, 2000 | 3.058B |
| December 31, 1999 | 2.547B |
| December 31, 1998 | 2.096B |
| December 31, 1997 | -385.10M |
| December 31, 1996 | 1.524B |
| December 31, 1995 | 1.307B |
| December 31, 1994 | 1.185B |
| December 31, 1993 | 491.10M |
| December 31, 1992 | 827.60M |
| December 31, 1991 | 1.315B |
| December 31, 1990 | 1.127B |
| December 31, 1989 | 939.50M |
| December 31, 1988 | 761.00M |
| December 31, 1987 | 410.50M |
| December 31, 1986 | 558.20M |
| December 31, 1985 | 517.60M |
| December 31, 1984 | 490.20M |
| December 31, 1983 | 457.40M |
| December 31, 1982 | 411.83M |
| December 31, 1981 | 374.48M |
| December 31, 1980 | 341.97M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Johnson & Johnson | 26.80B |
| Merck & Co., Inc. | 18.26B |
| Pfizer Inc. | 7.787B |
| Bristol Myers Squibb Co. | 7.056B |
| Atai Beckley, Inc. | -660.15M |